Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX)
Business numbers score is on the low side; smart-money score is near the top of its range, short-term momentum score is on the low side.
QNRX scores higher than 50% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) scores 40 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.04× 30-day average
- 52-week range
- 3.25 – 41.80
- Market cap
- $14.08M
- Earnings date
- 4 Nov 2026
- Volume
- 42,580
- Avg. volume (30d)
- 1,132,717
- Open
- 4.32
- Previous close
- 4.55
- Day's range (regular session)
- 4.25 – 4.68
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for QNRX
- 6 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for QNRX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about QNRX right now
Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) currently scores 40/100 on the Market Census six-factor composite, at the Average score level. QNRX is -1.10% on the day and +0.67% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in QNRX's data roughly balance out right now. QNRX's strongest factor is insider trades at 90/100 — a very strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See QNRX in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent QNRX news
Latest headlines that name Quoin Pharmaceuticals, Ltd. American, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and TherapyYahoo
- Quoin Pharmaceuticals Announces Publication Acceptance Of QRX003 Netherton Syndrome Manuscript Featuring Pediatric Compassionate-Use Case Report In Dermatology and Therapy IssueBenzinga
- Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin SyndromeYahoo
- Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICUYahoo
- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin SyndromeYahoo
We hide 1 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to QNRX’s 40, all within 1 point.
Sorted by closeness to QNRX’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.